Neobrave CCA

· Peking University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Neobrave CCA, covering 2026-01-28 to 2026-01-28. Get the full timeline:

Most recent: Clinical Trial Update: Perioperative Treatment of High-risk Resectable CCA With HAIC Plus A+T: Neobrave CCA [Phase 2]